Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Patent
1989-05-26
1991-11-26
Nucker, Christine
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
536 27, 935 77, 935 78, 530406, 436 64, 436813, C12Q 168, C07H 1512, C12N 1500, G01N 3348
Patent
active
050681753
ABSTRACT:
Methods and composition for detecting the presence of human ras oncogene related malignancies are provided, where a biological sample is assayed for protein(s) specific to a DNA sequence. In the methods of this invention, the test reaction involves admixing a biological sample from cancer patients or control donors with labelled ras oncogene promoter DNA. The admixture is incubated under conditions favorable for promoting specific interactions between proteins and the labelled DNA. Thereafter, the admixture is separated by charge and size in an electrophoretic field and the protein-DNA interactions are identified depending on the method of label employed. Bands migrating at a slower rate than the uncomplexed DNA are indicative of a protein-DNA interaction (i.e. circulating serum protein(s) from cancer patients interacting specifically with a region(s) of the ras oncogene promoter DNA). Utilizing this experimental protocol, the serum proteins of interest include at least four different proteins that specifically interact with a region or regions of the ras oncogene promoter DNA. The four different factors, ranging in molecular weight from about 200 Kd to about 50 Kd are proteinaceous in nature as demonstrated by their trypsin sensitivity and heat stability.
REFERENCES:
patent: 4699877 (1987-10-01), Cline et al.
patent: 4963658 (1990-10-01), Kurg et al.
Maniatis et al., Molecular Cloning-A Laboratory Manual, 1982, Cold Spring Harbor Laboratory, p. 151.
Ashii et al., Science, vol. 232, pp. 1410-1413 (1986).
C. J. Der et al., "Altered gene products are associated with activation of cellular ras genes in human lung and colon carcinomas," Cell 32:201-08 (1983).
L. A. Feig et al., "Somatic activation of ras gene in human ovarian carcinoma," Science 223:698-700 (1984).
M. S. McCoy et al., "Characterization of a human colon/lung carcinoma oncogene," Nature 302:79-81 (1983).
M. V. Viola et al., "Expression of ras oncogene p21 in prostate cancer," New Eng. J. of Med. 314:133-137 (1986).
S. Ishii et al., "Binding of the Spl transcription factor by the human Harvey rasl proto-oncogene promoter," Science 232:1410-1413 (1986).
H. Dosaka et al., "Immunohistochemical analysis of human lung cancers with anti-ras p21 monoclonal antibodies," Int. J. Biol. Markers 2(2):75-82 (1987).
P. Garrett et al., "Clinical utility of oncofetal proteins and hormones as tumor markers," Medical Clinics of N. Am. 70(b):1295-1306 (1986).
B. Czerniak et al., "ras oncogene p21 as a tumor marker in the cytodiagnosis of gastric and colonic carcinomas," Cancer 60:2432-2436 (1987).
L. M. Stock et al., "ras related oncogene protein as a tumor marker in transitional cell carcinoma of the bladder," J. of Urol. 137(4):789-792 (1987).
H. Honkawa et al., "Identification of the principal promoter sequence of the C-H-ras transforming oncogene: deletional analysis of the 5'-flanking region by focus formation," Mol. Cell. Biol. 7(8):2933-2940 (1987).
M. G. Borrello et al., "Modulation of the human Harvey-ras oncogene expression by DNA methylation," Oncogene Res. 2(2):197-203 (1988).
S. Ishii et al., "Promoter region of the human Harvey ras proto-oncogene: Similarity to the EGF receptor proto-oncogene promoter," Science 230(47 32):1378-1381 (1985).
G. E. Gallick et al., "Expression of p21 ras in fresh primary and mestastic human colorectal tumors," Proc. Natl. Acad. Sci. 82:1795-1799 (1985).
J. L. Bos et al., "Prevalence of ras gene mutations in human colorectal cancers," Nature 327:293-297 (1987).
Board of Regents, The University of Texas Sysem
Fleisher Mindy B.
Nucker Christine
LandOfFree
Method of detecting ras oncogene related malignancies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of detecting ras oncogene related malignancies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of detecting ras oncogene related malignancies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2385785